Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Ogden

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Pharmacy|August 1, 1988
'The personal growth opportunities that we can create in the VA will help in the recruitment and retention of pharmacists'J E Ogden
Trends in Biotechnology|March 1, 1992
Recombinant haemoglobin in the development of red-blood-cell substitutesJ E Ogden
Trends in Biotechnology|October 1, 1994
Thrombopoietin--the erythropoietin of platelets?J E Ogden
American Pharmacy|December 1, 1988
VA and APhA--common concernsJ E Ogden
Cognition|June 1, 1988
Knowledge for hunger: children's problem with representation in imputing mental statesJ Perner, J E Ogden
Trends in Biotechnology|February 1, 1995
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?J E Ogden, P K Moore
International Anesthesiology Clinics|January 1, 1995
The development of hemoglobin solutions as red cell substitutesJ E Ogden, E S Parry
Nucleic Acids Research|July 11, 1990
Nucleotide sequence of human lactoferrin cDNAM J Powell, J E Ogden
Current Genetics|January 1, 1986
Isolation of a novel type of mutation in the mitotic control of Schizosaccharomyces pombe whose phenotypic expression is dependent on the genetic background and nutritional environmentJ E Ogden, P A Fantes
Vox Sanguinis|January 1, 1995
Haemoglobin-based red cell substitutes: current statusJ E Ogden, S L Mac Donald
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Pharmacy|August 1, 1988
'The personal growth opportunities that we can create in the VA will help in the recruitment and retention of pharmacists'J E Ogden
Trends in Biotechnology|March 1, 1992
Recombinant haemoglobin in the development of red-blood-cell substitutesJ E Ogden
Trends in Biotechnology|October 1, 1994
Thrombopoietin--the erythropoietin of platelets?J E Ogden
American Pharmacy|December 1, 1988
VA and APhA--common concernsJ E Ogden
Cognition|June 1, 1988
Knowledge for hunger: children's problem with representation in imputing mental statesJ Perner, J E Ogden
Trends in Biotechnology|February 1, 1995
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?J E Ogden, P K Moore
International Anesthesiology Clinics|January 1, 1995
The development of hemoglobin solutions as red cell substitutesJ E Ogden, E S Parry
Nucleic Acids Research|July 11, 1990
Nucleotide sequence of human lactoferrin cDNAM J Powell, J E Ogden
Current Genetics|January 1, 1986
Isolation of a novel type of mutation in the mitotic control of Schizosaccharomyces pombe whose phenotypic expression is dependent on the genetic background and nutritional environmentJ E Ogden, P A Fantes
Vox Sanguinis|January 1, 1995
Haemoglobin-based red cell substitutes: current statusJ E Ogden, S L Mac Donald
Pageof 3